Seville buy MDMA pills
Seville buy MDMA pillsSeville buy MDMA pills
__________________________
📍 Verified store!
📍 Guarantees! Quality! Reviews!
__________________________
▼▼ ▼▼ ▼▼ ▼▼ ▼▼ ▼▼ ▼▼
▲▲ ▲▲ ▲▲ ▲▲ ▲▲ ▲▲ ▲▲
Seville buy MDMA pills
The Journal publishes scientific articles of different topics in the field of legal and forensic medicine which are represented as a learning tool of the specialty that gives the reader an update of different topics in the field of legal and forensic medicine. It also serves as continuing education in practical aspects of the daily work of the forensic physician in the field of the Administration of Justice. The Journal incorporates all groups- forensic physicians, specialists in legal and forensic medicine, university teachers, psychiatrists and psychologists, experts in the assessment of body injury, scientific police and legal experts interested in the subject. SRJ is a prestige metric based on the idea that not all citations are the same. SJR uses a similar algorithm as the Google page rank; it provides a quantitative and qualitative measure of the journal's impact. SNIP measures contextual citation impact by wighting citations based on the total number of citations in a subject field. The average number of weeks it takes from manuscript submission to the initial decision on the article. The use of toxic substances is a main risk factor for sudden cardiac death. The most relevant toxic substances are the illegal drugs especially cocaine , ethanol, tobacco, and doping substances. Additionally, several therapeutic drugs are able to increase the risk for sudden cardiac death. The aim of the present paper is to review the mechanism of action and the main pathological problems induced by toxic substances. Moreover, we provide epidemiological information, underlie the importance of a standardised forensic investigation, and discuss the role of forensic pathology in the prevention of this phenomenon. The possibility of consumption of any drug of abuse should be considered in any case of sudden cardiac death in adolescents, young, or middle-age patients, especially in men. In athletes the use of doping substances should be ruled-out. In patients under psychopharmacological treatment, the putative influence of these drugs should be borne in mind.. The use of toxic substances has been associated with the onset of both acute and chronic health problems. The harmful effects are particularly important for the cardiovascular system, and are a significant risk factor for sudden cardiac death SCD. Toxic substances, through transient functional disturbances, interact with the anatomical substrate responsible for SCD, triggering a fatal arrhythmia. In addition, toxic substances can cause chronic structural abnormalities, through sympathomimetic or direct cardiotoxic effects, which also increase the risk of SCD. In the field of forensic pathology, relevant toxic substances are not only illegal drugs, but also ethyl alcohol, tobacco and performance-enhancing drugs. Although they cannot strictly be considered toxic substances, several medicinal products also increase the risk of SCD, particularly psychotropic drugs. Few studies based on forensic autopsies have analysed the association between SCD and the use of toxic substances. The main risk factor for SCD was the recent use of cocaine risk multiplied fourfold , followed by smoking risk increased twofold. The prevalence of SCD associated with toxic substances is not well defined and the pathophysiological mechanisms are not clearly established. Controlled epidemiological studies based on forensic autopsies are required in order to better understand this phenomenon. Forensic research provides a rich contribution to the understanding of these deaths for several reasons: a it provides additional evidence to the information collected in studies based on hospital populations or emergencies; b it allows reliable epidemiological figures to be obtained; c it allows both histopathological and toxicological studies to be carried out, offering reliable data which cannot be determined in clinical studies; and d it enables a chronological pattern to be established between the use of the substance and the pathological findings observed. This article reviews the association between the use of toxic substances and SCD, providing data on the mechanism of action and the condition induced by the main substances. In addition, it offers epidemiological information, highlights the significance of a standardised forensic investigation and discusses the implications of forensic pathology in preventing this phenomenon. In general, it entails polydrug use, involving the use of different substances. The most used illegal drug is cannabis, followed by various stimulants, such as cocaine and amphetamine derivatives, the use of which is significantly lower. Rates of recent use of various toxic substances in Spain. Epidemiological studies have shown that the moderate consumption of alcohol is associated with a reduced risk of cardiovascular diseases, representing a protective effect against SCD. Population studies have shown a clear association between excessive alcohol intake and risk of SCD. The pro-arrhythmogenic effect of alcohol could be responsible for some of these deaths, although the mechanisms are still not properly understood. Some studies have argued that the association could be explained by the finding of a prolonged QT interval in alcoholics. Furthermore, chronic and excessive alcohol consumption is one of the main causes of dilated cardiomyopathy. Diagnosis is based on the identification of dilated cardiomyopathy, without a justifying cause, in a patient with a history of alcohol abuse. The aetiopathogenic mechanism has not yet been clarified and several hypotheses have been proposed: direct toxic effect on cardiomyocytes, structural changes in contractile proteins, dysfunction of intracellular organelles, abnormalities in calcium homeostasis and direct stimulation of neurohormonal systems. From an anatomopathological point of view, it is indistinguishable from other types of dilated cardiomyopathy. This is why early diagnosis is of particular interest. Smoking is a major cause of cardiovascular morbidity and mortality. Deaths from coronary artery disease are significantly reduced in smokers who quit compared to those who continue smoking. In forensic studies, in which it can be difficult to obtain detailed information on this history, the histopathological finding of respiratory bronchiolitis can be useful to confirm tobacco use. Cocaine use causes significant adverse effects on the cardiovascular system due to its action on the coronary arteries and the myocardium. All of the above means that cocaine is a major risk factor for SCD; a risk that increases when it is used together with other substances, which is especially common in the case of alcohol and tobacco. Mechanisms associated with the increased risk of sudden cardiac death due to cocaine use. The concomitant use of cocaine and ethanol elicits the production of an active metabolite, cocaethylene, which is more toxic than cocaine and alcohol when they are used alone and increases the risk of SCD by fold. The association of cocaine and tobacco facilitates the onset of premature and accelerated coronary atherosclerosis. Accelerated atherosclerosis. Repeated administration of cocaine causes endothelial damage which promotes the early onset of coronary atherosclerosis. The study by Lucena et al. Cocaine is also associated with intravascular thrombosis in the coronary and peripheral arteries. Scientific evidence suggests that cocaine activates platelet aggregation and stimulates the secretion of thrombogenic substances from the vascular endothelium. Coronary atherosclerosis, with or without occlusive thrombosis, elicits acute or chronic myocardial ischaemia. Intramyocardial small-vessel disease. Myocardial perfusion can reduce despite the epicardial arteries being free from atherosclerosis. This phenomenon is related to the thickening of the middle muscle layer of the intramyocardial arterioles secondary to maintained vasoconstriction caused by the chronic effects of cocaine. Cardiomegaly with left ventricular hypertrophy. Cardiac hypertrophy, on its own and in isolation, increases the risk of SCD. Myocardial fibrosis. The high prevalence of myocardial fibrosis in deaths related to cocaine or amphetamines reveals the existence of previous ischaemic episodes. Underlying silent ischaemia, myocardial fibrosis as a substrate for the re-entry arrhythmic phenomena or both can increase the risk of arrhythmias. In cases of cardiac hypertrophy secondary to the increased filling pressure, there is also a progressive accumulation of collagen fibres in the myocardial interstitium, especially in the left ventricle. Eosinophilic myocarditis. This condition has been described as a consequence of the adverse reaction to different drugs, including cocaine. Aortic dissection. Published cases on aortic dissection associated with cocaine are rare and most are related to the use of crack cocaine and to severe hypertension and direct damage on the aorta by catecholamines. Amphetamines are substances which are structurally related to phenylethylamine. They include recreational drugs, such as methamphetamine and methylenedioxymethamphetamine, and medicines such as methylphenidate and phendimetrazine. These medicines are currently limited to the treatment of attention deficit hyperactivity disorder, narcolepsy and short-term weight loss. The pharmacodynamics of amphetamines and their derivatives on the cardiovascular system is similar to that of cocaine, although they present certain particularities. The main toxic effects are mediated by the release of catecholamines, which determines the stimulation of peripheral alpha- and beta-adrenergic receptors, causing a sympathomimetic syndrome. Other pharmacological actions are the inhibition of monoamine oxidase; serotonergic agonist activity; and the increased release of vasopressin. Cardiovascular complications are similar to those of cocaine: greater-than-expected heart weight, areas of fibrosis, cardiomyocyte hypertrophy and contraction band necrosis. They also present greater susceptibility to accelerated atherosclerosis and to intramyocardial small-vessel disease. The anatomical changes referred to act as a morphological substrate of SCD and the high concentrations of catecholamines as an initiator phenomenon in the production of arrhythmias. Some authors have described symptoms of acute myocardial ischaemia after consumption of amphetamine derivatives used in the treatment of attention deficit hyperactivity disorder in adolescents with normal coronary arteries. The symptoms have been related to coronary spasm. The risk of cardiovascular complications related to the use of cannabis is considered low in healthy subjects. By contrast, the acute effects of cannabis can act as precipitating factors of SCD in patients with a high risk of coronary events. It has been reported that the acute use of cannabis increases the risk of infarction almost fivefold, and it is also a significant risk factor associated with the onset of acute cerebral ischaemia. The cardiovascular effects produced by heroin do not seem to play an important role in the morbidity and mortality of this drug. Death is generally due to respiratory depression or to an adverse drug reaction, and is not usually associated with SCD. Methadone is the drug most commonly used as opioid replacement therapy in addiction therapies, but it is also used as an analgesic and as a recreational drug. Its adverse effects include respiratory depression and QT prolongation. It is therefore recommended to perform a prior ECG on opioid addicts who are integrated into methadone programmes. The use of substances with the aim of illegally enhancing sporting performance is recognised as common practice and extends beyond elite sporting activities, with a cost for health and a link to SCD which is becomingly increasingly well-known. Almost all of these illegal substances, especially anabolic steroids, stimulants and peptide hormones, can cause arrhythmogenic effects both due to an increase in focal automatism and to enhancing electrophysiological heterogeneity, and they are triggering factors of re-entry arrhythmias. All of this occurs both at the supraventricular and ventricular level, with the known vital risk that it entails, particularly in the context of facilitating elite sporting performance. The mechanisms of intervention are very diverse. Some are not fully established and almost always have a link to the pattern of use and individual susceptibility. Anabolic-androgenic steroids deserve special mention because of their particularly deleterious cardiovascular consequences. In the myocardium, it translates into the abnormal apposition of muscle fibres and left ventricular hypertrophy, as well as into diastolic dysfunction, 44 and in the long term to subendocardial ischaemia, cardiomyocyte disorganisation with myocardial fibrosis and dilation and systolic dysfunction. Furthermore, these substances have collateral systemic effects: they alter the lipid metabolism and are linked to endothelial dysfunction, hypertension, 47 procoagulability and therefore coronary artery disease. They alter the parasympathetic innervation, cause QT interval dispersion and increase intracellular calcium, 48 which is a potential cause of arrhythmias and SCD when associated with the histological abnormalities mentioned. These effects are dose-dependent and are almost always related to the quantity and time of use. Therefore, the clinical diagnosis of a potentially fatal cardiac arrhythmia, particularly in the presence of a latent electrophysiological substrate, which includes some hereditary cardiomyopathies with a risk of sudden death, should raise the suspicion that an illegal substance could be a precipitating cause, and this link should be investigated. Acquired long QT syndrome is a condition which is related to SCD in a normally structured heart and is caused mainly by the use of drugs. The monitoring centre of the World Health Organisation 50 issues reports regarding drugs with the capacity to induce symptomatic long QT syndrome Table 2. Alongside this, the Mayo Clinic has contributed to structuring this alert and has developed a risk scale, which is widely used in daily clinical practice and on which the updated list on the CredibleMeds Website is based. Drugs with known risk of torsades de pointes. The QT interval depends on multiple ion channels, and it has been recognised as a risk marker for ventricular fibrillation in the form of torsades de pointes associated with the effect of different drugs. Risk factors for drug-induced arrhythmogenicity. Another syndrome which has been linked to SCD in structurally normal hearts is Brugada syndrome. There are several drugs which inhibit the sodium channel SCN5, among others which produce an electrocardiographic pattern typical of Brugada and are therefore associated with an arrhythmic risk. There are a series of medicines which should be avoided in patients diagnosed with this syndrome due to their degree of risk. There are clinical practice guidelines which also establish risk gradients www. The prevention of arrhythmic SD associated with the pro-arrhythmogenic effects of drugs may require hospital monitoring, minimising synergistic interactions as much as possible and, above all, preventing exposure, favouring the selection of drugs with a better safety profile, particularly in cases with greater susceptibility. There is also evidence concerning the adverse cardiovascular risk profile for antipsychotic drugs, especially phenothiazines, related to an increase in classic cardiovascular risk factors. However, several studies have shown a trend towards the development of insulin resistance and dyslipidaemia, as well as reduced distensibility in medium-calibre arteries in psychiatric patients undergoing antipsychotic treatment compared to controls with no treatment. In the forensic pathology field, there is also evidence that some psychotropic drugs increase the risk of SCD, even at post-mortem therapeutic concentrations. In a study on forensic autopsies, it was observed that the percentage of cases with positive toxicology psychotropic drugs were the most frequently detected substances was significantly higher in SCD in structurally normal hearts than in SCD with structural pathology, which suggests that these substances may play a proarrhythmic role. In the event of SCD, a complete forensic investigation should be conducted to establish the cause of death and its triggering factors, including toxic substances, even when structural disease which justifies the death has been detected in the autopsy. The macroscopic and histopathological study will also make it possible to determine the existence of organic disease in relation to the acute or chronic use of toxic substances. Toxicological analyses are essential, not only to exclude death of toxic origin, but also to determine the use of drugs, performance-enhancing drugs and medicines which may have been able to act as triggering factors of the death. In terms of sampling, it is essential to send blood ideally peripheral blood , urine and vitreous humour in all cases. Depending on the case, other samples, such as gastric content, could be sent. Analysis of hair is useful to establish the history of exposure to recreational drugs and to determine the implication of a substance in the cause of death. It must be remembered that some modern synthetic drugs, such as synthetic cannabinoids, are not currently detected in the routine screening of toxicology laboratories. Although the association between drugs and SCD is well established, in practice it may be difficult to determine the exact underlying mechanism in a specific case; i. This is due to the interplay of multiple factors, such as the route of administration, the dose used, tolerance, individual vulnerability, the associated risk factors, the concomitant use of diverse substances which interact with them, etc. Interpretation is further hindered by the complexity of post-mortem toxicology and the overlap which exists between therapeutic and toxic concentrations for many substances. The possibility of using recreational drugs should be taken into account in all sudden deaths of adolescents, young people or even middle-aged adults, particularly males. It would also be advisable to rule out the use of performance-enhancing drugs in athletes and to assess the influence of performance-enhancing drugs in patients who took psychotropic drugs, even with post-mortem therapeutic levels. In the absence of another cause of death, the possibility of arrhythmic death due to acquired long QT syndrome or Brugada syndrome should be considered. In the prevention of SCD, it is important to identify the modifiable risk factors which trigger fatal arrhythmia, as this offers a good approximation for the development of effective strategies. Therefore, actions aimed at detecting and controlling these factors and educational campaigns on the cardiovascular risks of recreational drugs could be effective at preventing SCD. The authors declare that they have no conflicts of interest. Rev Esp Med Legal. ISSN: Previous article Next article. Issue 1. Pages January - March More article options. DOI: The role of toxic substances in sudden cardiac death. Download PDF. Benito Morentin a , Luis F. Corresponding author. This item has received. Article information. Table 1. Mechanisms associated with the increased risk of sudden cardiac death due to cocaine use.. Table 2. Drugs with known risk of torsades de pointes.. Show more Show less. In patients under psychopharmacological treatment, the putative influence of these drugs should be borne in mind. Forensic pathology. Palabras clave:. Full Text. Introduction The use of toxic substances has been associated with the onset of both acute and chronic health problems. Figure 1. SCD: sudden cardiac death. Table 3. Lucena, M. Blanco, C. Jurado, A. Rico, M. Salguero, R. Cocaine-related sudden death: a prospective investigation in south-west Spain. Eur Heart J, 31 , pp. Morentin, J. Ballesteros, L. Callado, J. Recent cocaine use is a significant risk factor for sudden cardiovascular death in 15—year-old subjects: a forensic case—control study. Addiction, , pp. Bjune, B. Risgaard, L. Kruckow, C. Glinge, O. Ingemann-Hansen, P. Leth, et al. Post-mortem toxicology in young sudden cardiac death victims: a nationwide cohort study. Europace, , pp. Informe Europeo sobre Drogas Tendencias y novedades. Gorgels, M. Weijenberg, W. Dubois-Arbouw, B. Golombeck, J. Risk indicators for out-of-hospital cardiac arrest in patients with coronary artery disease. J Clin Epidemiol, 52 , pp. Brien, P. Ronksley, B. Turner, K. Mukamal, W. Effect of alcohol consumption on biological markers associated with risk of coronary heart disease: systematic review and meta-analysis of interventional studies. BMJ, , pp. Cook, Q. Wang, M. Tiainen, T. Tynkkynen, A. Kangas, et al. Metabolic profiling of alcohol consumption in young adults. Int J Epidemiol, 45 , pp. Day, O. James, T. Butler, R. QT prolongation and sudden cardiac death in patients with alcoholic liver disease. Lancet, , pp. Achaiah, N. Intoxication with alcohol: an underestimated trigger of Brugada syndrome?. JRSM Open, 7 ,. Klein, A. Gardiwal, A. Schaefer, B. Panning, D. Effect of ethanol on cardiac single sodium channel gating. Forensic Sci Int, , pp. Lucena, P. Garamendi, G. Guzzo-Merello, P. Cardiovascular pathology secondary to alcohol consumption, drugs of abuse and medication. Clinico-pathological atlas of cardiovascular diseases, pp. Guzzo-Merello, J. Segovia, F. Dominguez, M. Cobo-Marcos, M. Gomez-Bueno, P. Avellana, et al. Natural history and prognostic factors in alcoholic cardiomyopathy. Hallstrom, L. Cobb, R. Smoking as a risk factor for recurrence of sudden cardiac arrest. N Engl J Med, , pp. Priori, E. Aliot, C. Blomstrom-Lundqvist, L. Bossaert, G. Breithardt, P. Brugada, et al. Task force on sudden cardiac death of the European Society of Cardiology. Eur Heart J, 22 , pp. Burke, A. Farb, G. Malcom, Y. Liang, J. Smialek, R. Coronary risk factors and plaque morphology in men with coronary disease who died suddenly. Barua, J. Mechanisms of coronary thrombosis in cigarette smoke exposure. Arterioscler Thromb Vasc Biol, 33 , pp. Afonso, T. Mohammad, D. Crack whips the heart: a review of the cardiovascular toxicity of cocaine. Am J Cardiol, , pp. Harris, E. Everhart, J. Mendelson, R. The pharmacology of cocaethylene in humans following cocaine and ethanol administration. Drug Alcohol Depend, 72 , pp. Moliterno, J. Willard, R. Lange, B. Negus, J. Boehrer, D. Glamann, et al. Coronary-artery vasoconstriction induced by cocaine, cigarette smoking, or both. Bachi, V. Mani, D. Jeyachandran, Z. Fayad, R. Goldstein, N. Virmani, M. Robinowitz, S. Smialek, D. Cardiovascular effects of cocaine: an autopsy study of 40 patients. Am Heart J, , pp. Forensic histopathology. Fundamentals and perspectives, pp. Hsue, C. Salinas, A. Bolger, N. Benowitz, D. Acute aortic dissection related to crack cocaine. Circulation, , pp. Palmiere, S. Burkhardt, C. Staub, M. Hallenbarter, G. Pizzolato, R. Dettmeyer, et al. Thoracic aortic dissection associated with cocaine abuse. Frishman, A. Del Vecchio, S. Sanal, A. Cardiovascular manifestations of substance abuse. Part 2: alcohol, amphetamines, heroin, cannabis, and caffeine. Heart Dis, 5 , pp. Patel, M. Belson, D. Wright, H. Lu, M. Heninger, M. Methylenedyoximethamphetamine ecstasy -related myocardial hypertrophy: an autopsy study. Resuscitation, 66 , pp. Fatal coronary artery intimal hyperplasia due to amphetamine use. Cardiovasc Pathol, 22 , pp. Turillazi, I. Pathology of the heart and sudden death in forensic medicine, pp. Jiao, S. Velez, J. Ringstad, V. Eyma, D. Miller, M. Myocardial infarction associated with Adderall XR and alcohol use in a young man. J Am Board Fam Med, 22 , pp. Rostagno, S. Caciolli, M. Felici, F. Gori, J. Dilated cardiomyopathy associated with chronic consumption of phendimetrazine. Landau, J. Jackson, J. A case of demand ischemia from phendimetrazine. Cases J, 1 , pp. Kang, A. Zhang, H. Kim, S. Yoo, C. Sun, S. Acute cardiac death associated with polipharmacy during use of anti-obesity drug. Basic Appl Pathol, 1 , pp. Jouanjus, V. Raymond, M. Lapeyre-Mestre, V. What is the current knowledge about the cardiovascular risk for users of cannabis-based products? A systematic review. Curr Atheroscler Rep, 19 , pp. Hartung, S. Kauferstein, S. Ritz-Timme, T. Sudden unexpected death under acute influence of cannabis. Trecki, R. Gerona, M. Synthetic cannabinoid-related illnesses and deaths. Roy, C. McCarthy, G. Kiernan, C. McGorrian, E. Keenan, N. Mahon, et al. Increased incidence of QT interval prolongation in a population receiving lower doses of methadone maintenance therapy. Chugh, C. Socoteanu, K. Reinier, J. Waltz, J. Jui, K. A community-based evaluation of sudden death associated with therapeutic levels of methadone. Am J Med, , pp. WADA, , pp. Melchert, A. Cardiovascular effects of androgenicanabolic steroids. Med Sci Sports Exerc, 27 , pp. Montisci, R. El Mazloum, G. Cecchetto, C. Terranova, S. Ferrara, G. Thiene, et al. Anabolic androgenic steroids abuse and cardiac death in athletes: morphological and toxicological findings in four fatal cases. Nottin, L. Nguyen, M. Terbah, P. Cardiovascular effects of androgenic anabolic steroids in male bodybuilders determined by tissue Doppler imaging. Am J Cardiol, 97 , pp. Pluim, A. Zwinderman, A. The athlete's heart. A meta-analysis of cardiac structure and function. Urhausen, T. Albers, W. Are the cardiac effects of anabolic steroid abuse in strength athletes reversible?. Heart, 90 , pp. Sader, K. Griffiths, R. McCredie, D. Handelsman, D. Androgenic anabolic steroids and arterial structure and function in male bodybuilders. J Am Coll Cardiol, 37 , pp. Medei, M. Marocolo, D. Rodrigues, P. Arantes, C. Takiya, J. Silva, et al. Chronic treatment with anabolic steroids induces ventricular repolarization disturbances: cellular, ionic and molecular mechanism. J Mol Cell Cardiol, 49 , pp. Goldenberg, A. J Am Coll Cardiol, 51 , pp. Ray, C. Chung, K. Murray, K. Hall, C. Atypical antipsychotic drugs and the risk of sudden cardiac death. N Eng J Med, , pp. Schwartz, R. Predicting the unpredictable: drug-induced QT prolongation and Torsades de Pointes. JACC, 67 , pp. Antzelevitch, P. Brugada, M. Borggrefe, J. Brugada, R. Brugada, D. Corrado, et al. Wood, D. Yap, A. Drug induced QT prolongation and torsades de pointes. Heart, 89 , pp. Findikli, M. Nacitarhan, M. Camkurt, H. Findikli, S. Clin Psychopharmacol Neurosci, 14 , pp. Basso, M. Burke, P. Fornes, P. Gallagher, R. Sheppard, et al. Guidelines for autopsy investigation of sudden cardiac death. Virchows Arch, , pp. Subscribe to our newsletter. Instructions for authors Submit an article Ethics in publishing Language Editing services. Recommended articles. Risk factors for completed suicide in young people and Forensic population study of sudden unexplained death in Chemical submission in cases of alleged crimes against Article options. Risk factors for completed suicide in young people and middle-aged adults: Population forensic study. Ischaemic heart disease. Acute myocardial infarction Replacement fibrosis Coronary thrombosis. Hypersensitivity reaction. Class I: sodium channel blockers. Class III: potassium channel blockers. Antimalarials Cytostatic agents. Cholinesterase inhibitors. Non-sedating or 2nd generation. Patient-specific risk factors. Congenital long QT syndrome. Advanced age. Cardiac ischaemia. Heart failure, left ventricular dysfunction. Significant ventricular hypertrophy. Hydroelectrolytic disorders: hypokalaemia, hypomagnesaemia, hypocalcaemia. Possible genetic predisposition. Potentially avoidable risk factors. Concomitant treatment with diuretics. Pharmacokinetic drug interactions. Combination of more than one drug with the capacity to prolong QTc.
Homemade synthetic drug laboratory raided in Seville
Seville buy MDMA pills
The arrival of a package from Holland with psychoactive substances inside set in motion the joint operation between both bodies. June 6, As a result of the searches, more than 1. The investigation began after the interception of a package originating in the Netherlands and destined for Seville, inside which around grams of the so-called New Psychoactive Substances NSP were found. Once this shipment was intercepted, a device made up of agents from both bodies was established to determine the recipient of the same. Finally, last April, the person who received the package was arrested, and among his belongings were found numerous single-dose bags ready for sale containing different types of psychotropic substances, as well as fractional amounts of money, which made investigators suspect the existence of a place where these drugs were prepared for later distribution. Thanks to the actions of the agents, it was possible to identify and locate the place where these types of substances were processed, carrying out different searches in several properties, and in one of them finding a home laboratory for preparing synthetic drugs. More than 1. Precision scales, glass smoking pipes, bottles and dropper pipettes were also seized, as well as 22, euros and 2, dollars in cash. Once the police investigation was completed, all the seized items were placed at the disposal of the judicial authorities, in addition to the main suspect, who was ordered to be sent to prison. This operation dismantles a home-based production centre dedicated to the preparation and distribution of synthetic drugs in Seville, linked to 'chemsex', substances whose consumption is linked to sexual practices.
Seville buy MDMA pills
Homemade synthetic drug laboratory raided in Seville
Seville buy MDMA pills
Seville buy MDMA pills
Homemade synthetic drug laboratory raided in Seville
Buying ganja online in Famagusta
Seville buy MDMA pills
Seville buy MDMA pills
Seville buy MDMA pills
Buying marijuana online in Daylesford
Buy weed online in Liechtenstein
Seville buy MDMA pills